The Effect of Doubling the Statin Dose on Pro-Inflammatory Cytokine in Patients With Triple-Vessel Coronary Artery Disease |
Kim, Yoo-Ri
(Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center)
Park, Jae-Hong (Department of Cardiology, Han-Il General Hospital) Lee, Hye-Jin (Department of Endocrinology, Ewah Womans University School of Medicine, Ewha University Medical Center) Pyun, Wouk-Bum (Department of Cardiology, Ewah Womans University School of Medicine, Ewha University Medical Center) Park, Si-Hoon (Department of Cardiology, Ewah Womans University School of Medicine, Ewha University Medical Center) |
1 | Libby P, Sasiela W. Plaque stabilization: can we turn theory into evidence? Am J Cardiol 2006;98(11A):26P-33P. DOI |
2 | Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97. DOI ScienceOn |
3 | Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207. DOI ScienceOn |
4 | Biloglav Z, Ivankovic´ D, Campbell H, Rudan I. Performance of WHO Angina Questionnaire in measuring burden of coronary heart disease in human isolate populations. Coll Antropol 2004;28:205-13. |
5 | Murphy NF, Stewart S, Hart CL, MacIntyre K, Hole D, McMurray JJ. A population study of the long-term consequences of Rose angina: 20- year follow-up of the Renfrew-Paisley Study. Heart 2006;92:1739- 46. DOI ScienceOn |
6 | Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70. DOI ScienceOn |
7 | Mills R, Bhatt DL. The Yin and Yang of arterial inflammation. J Am Coll Cardiol 2004;44:50-2. DOI ScienceOn |
8 | Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-34. DOI ScienceOn |
9 | Apple FS, Wu AH, Mair J, et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005;51:810-24. DOI ScienceOn |
10 | Shishehbor MH, Bhatt DL, Topol EJ. Using C-reactive protein to assess cardiovascular disease risk. Cleve Clin J Med 2003;70:634-40. DOI ScienceOn |
11 | Kofler S, Nickel T, Weis M. Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin Sci (Lond) 2005; 108:205-13. DOI ScienceOn |
12 | LaRosa JC. Pleiotropic effects of statins and their clinical significance. Am J Cardiol 2001;88:291-3. DOI ScienceOn |
13 | Shishehbor MH, Brennan ML, Aviles RJ, et al. Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation 2003;108:426-31. DOI ScienceOn |
14 | Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001;344:1959-65. DOI ScienceOn |
15 | Morrow DA, de Lemos JA, Sabatine MS, et al. Clinical relevance of Creactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial. Circulation 2006;114:281-8. DOI ScienceOn |
16 | Wenger NK, Lewis SJ, Herrington DM, Bittner V, Welty FK; the Treating to New Targets Study Steering Committee and Investigators. Outcomes of using high- or low- dose atorvastatin in patients 65 years age or older with stable coronary heart disease. Ann Intern Med 2007;147:1-9. DOI ScienceOn |
17 | Ridker PM, Morrow DA, Rose LM, Rifai N, Cannon CP, Braunwald E. Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 Trial. J Am Coll Cardiol 2005;45:1644-8. DOI ScienceOn |
18 | Ambrose JA, Martinez EE. A new paradigm for plaque stabilization. Circulation 2002;105:2000-4. DOI ScienceOn |
19 | Alsheikh-Ali AA, Maddukuri PV, Han H, Karas RH. Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials. J Am Coll Cardiol 2007;50:409-18. DOI ScienceOn |
![]() |